Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
Journal Article
·
· Nature Structural & Molecular Biology
more »
- National Inst. of Health (NIH), Bethesda, MD (United States)
- Univ. of Washington, Seattle, WA (United States)
- National Inst. of Health (NIH), Bethesda, MD (United States); Univ. of Texas, Austin, TX (United States)
- Univ. of California, San Francisco, CA (United States)
- Univ. of Texas, Austin, TX (United States)
- National Human Genome Research Institute, NIH, Bethesda, MD (United States)
- Frederick National Lab. for Cancer Research, MD (United States)
- Duke Univ. Medical Center, Durham, NC (United States)
- National Inst. for Communicable Diseases of the National Health Lab. Service, Johannesburg (South Africa); Univ. of KwaZulu-Natal, Congella (South Africa)
- National Inst. for Communicable Diseases of the National Health Lab. Service, Johannesburg (South Africa); Univ. of the Witwatersrand, Johannesburg (South Africa); Univ. of KwaZulu-Natal, Congella (South Africa)
- National Inst. of Health (NIH), Bethesda, MD (United States); Columbia Univ., New York, NY (United States)
Broadly neutralizing antibodies (bNAbs) against HIV-1 Env V1V2 arise in multiple donors. However, atomic-level interactions had previously been determined only with antibodies from a single donor, thus making commonalities in recognition uncertain. Here we report the cocrystal structure of V1V2 with antibody CH03 from a second donor and model Env interactions of antibody CAP256-VRC26 from a third donor. These V1V2-directed bNAbs used strand-strand interactions between a protruding antibody loop and a V1V2 strand but differed in their N-glycan recognition. Ontogeny analysis indicated that protruding loops develop early, and glycan interactions mature over time. Altogether, the multidonor information suggested that V1V2-directed bNAbs form an 'extended class', for which we engineered ontogeny-specific antigens: Env trimers with chimeric V1V2s that interacted with inferred ancestor and intermediate antibodies. As a result, the ontogeny-based design of vaccine antigens described here may provide a general means for eliciting antibodies of a desired class.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States)
- Sponsoring Organization:
- Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery; Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery; Frederick National Laboratory for Cancer Research; Intramural Research Program of the Vaccine Research Center; NIH; U.S. National Inst. of Allergy and Infectious Diseases (NIAID); USDOE Office of Science (SC), Basic Energy Sciences (BES) (SC-22)
- Grant/Contract Number:
- W-31109-ENG-38
- OSTI ID:
- 1238279
- Journal Information:
- Nature Structural & Molecular Biology, Journal Name: Nature Structural & Molecular Biology Journal Issue: 1 Vol. 23; ISSN 1545-9993
- Publisher:
- Nature Publishing GroupCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency
Journal Article
·
Thu May 25 20:00:00 EDT 2017
· eLife
·
OSTI ID:1628872
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency
Journal Article
·
Fri Oct 16 20:00:00 EDT 2015
· Journal of Virology
·
OSTI ID:1242300